Highlighted
D007 Acute Lymphoblastic Leukemia - Now with Extended Coverage
D007 Acute Lymphoblastic Leukemia just received an update, with version B1 featuring new probes that increase the coverage of ALL-relevant regions and target genes of emerging interest for ALL.
Our Products are IVDR-Certified!
We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! Very soon, the first batch of flagship products will be available on the market under the new IVDR, well in advance of the transition period deadline.
MCR Holland Prices in 2025
Effective from 1 January 2025, we will be implementing a price increase of approximately 1.9% on most of our products.
